ADCC-mediating antibodies have been shown to reduce mother-to-child HIV-1 transmission (25, –, 27) and slow virus disease progression (27, –, 29), and in RV144 they were correlated with reduced risk of infection in vaccine recipients with lower anti-Env plasma IgA responses (7). Here, CD79A is linked to infection.